William L. Musick

1.4k total citations
24 papers, 1.1k citations indexed

About

William L. Musick is a scholar working on Infectious Diseases, Epidemiology and Molecular Medicine. According to data from OpenAlex, William L. Musick has authored 24 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Infectious Diseases, 12 papers in Epidemiology and 5 papers in Molecular Medicine. Recurrent topics in William L. Musick's work include Antibiotic Resistance in Bacteria (5 papers), Antimicrobial Resistance in Staphylococcus (5 papers) and Clostridium difficile and Clostridium perfringens research (5 papers). William L. Musick is often cited by papers focused on Antibiotic Resistance in Bacteria (5 papers), Antimicrobial Resistance in Staphylococcus (5 papers) and Clostridium difficile and Clostridium perfringens research (5 papers). William L. Musick collaborates with scholars based in United States, Australia and Pakistan. William L. Musick's co-authors include Katherine K. Perez, Patricia L. Cernoch, James M. Musser, Randall J. Olsen, L. E. Peterson, James R. Davis, Geoffrey A. Land, Jessica Cottreau, Vincent H. Tam and Kady Phe and has published in prestigious journals such as SHILAP Revista de lepidopterología, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

William L. Musick

23 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
William L. Musick United States	13	557	476	355	339	301	24	1.1k
Katherine K. Perez United States	13	707 1.3×	457 1.0×	348 1.0×	229 0.7×	386 1.3×	27	1.2k
Twisha S Patel United States	16	257 0.5×	439 0.9×	214 0.6×	370 1.1×	296 1.0×	59	958
Matthaios Papadimitriou‐Olivgeris Switzerland	19	294 0.5×	490 1.0×	552 1.6×	530 1.6×	299 1.0×	98	1.3k
Christine B. Teng Singapore	12	432 0.8×	289 0.6×	289 0.8×	215 0.6×	354 1.2×	24	860
Kenneth Klinker United States	19	369 0.7×	494 1.0×	575 1.6×	189 0.6×	210 0.7×	42	1.1k
Elizabeth Neuner United States	20	365 0.7×	612 1.3×	345 1.0×	793 2.3×	335 1.1×	53	1.4k
Shawn H. MacVane United States	17	312 0.6×	426 0.9×	164 0.5×	517 1.5×	326 1.1×	34	977
Jeffrey Graves United States	8	685 1.2×	363 0.8×	860 2.4×	239 0.7×	192 0.6×	9	1.3k
Pilar Retamar Spain	14	411 0.7×	492 1.0×	160 0.5×	576 1.7×	410 1.4×	34	1.2k
Grace C. Lee United States	17	167 0.3×	328 0.7×	339 1.0×	271 0.8×	201 0.7×	41	1.1k

Countries citing papers authored by William L. Musick

Since Specialization

Citations

This map shows the geographic impact of William L. Musick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William L. Musick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William L. Musick more than expected).

Fields of papers citing papers by William L. Musick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William L. Musick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William L. Musick. The network helps show where William L. Musick may publish in the future.

Co-authorship network of co-authors of William L. Musick

This figure shows the co-authorship network connecting the top 25 collaborators of William L. Musick. A scholar is included among the top collaborators of William L. Musick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William L. Musick. William L. Musick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Yi, et al.. (2023). Ruptured intraventricular brain abscesses due to Fusobacterium nucleatum with obstructive hydrocephalus: illustrative case. Journal of Neurosurgery Case Lessons. 5(3). 2 indexed citations

Perez, Katherine K., et al.. (2023). Risk of Acute Kidney Injury Based on Vancomycin Target Trough Attainment Strategy: Area-Under-the-Curve-Guided Bayesian Software, Nomogram, or Trough-Guided Dosing. Annals of Pharmacotherapy. 58(2). 110–117. 4 indexed citations

Musick, William L., et al.. (2022). Extensively Drug-Resistant Myroides odoratus in Critically Ill Patients: A Case Series and Literature Review. SHILAP Revista de lepidopterología. 2022. 1–7. 7 indexed citations

Eubank, Taryn A, Constance M. Mobley, Mark J. Hobeika, et al.. (2021). Successful Treatment of Invasive Mucormycosis in Orthotopic Liver Transplant Population. SHILAP Revista de lepidopterología. 2021. 1–7. 6 indexed citations

Patel, Samir J., et al.. (2020). Clinical Outcomes Following Tocilizumab Administration in Mechanically Ventilated Coronavirus Disease 2019 Patients. Critical Care Explorations. 2(10). e0232–e0232. 6 indexed citations

Patel, Samir J., Richard J. Knight, Edward A. Graviss, et al.. (2019). Ciprofloxacin for BK viremia prophylaxis in kidney transplant recipients: Results of a prospective, double-blind, randomized, placebo-controlled trial. American Journal of Transplantation. 19(6). 1831–1837. 16 indexed citations

Davis, Michelle, et al.. (2018). Multicentre derivation and validation of a simple predictive index for healthcare-associated Clostridium difficile infection. Clinical Microbiology and Infection. 24(11). 1190–1194. 12 indexed citations

Lee, Jonathan J., et al.. (2017). Ceftazidime/avibactam use for carbapenem-resistant Klebsiella pneumoniae meningitis: a case report. Journal of Antimicrobial Chemotherapy. 73(1). 254–256. 40 indexed citations

Alam, Mohammad Jahangir, Seth T. Walk, Bradley T. Endres, et al.. (2017). Community Environmental Contamination of Toxigenic Clostridium difficile. Open Forum Infectious Diseases. 4(1). ofx018–ofx018. 44 indexed citations

10.

Patel, Samir J., et al.. (2016). Combination Drug Products for HIV–A Word of Caution for the Transplant Clinician. American Journal of Transplantation. 16(8). 2479–2482. 18 indexed citations

11.

Perez, Katherine K., et al.. (2016). Integrating Rapid Diagnostics and Antimicrobial Stewardship in Two Community Hospitals Improved Process Measures and Antibiotic Adjustment Time. Infection Control and Hospital Epidemiology. 37(4). 425–432. 70 indexed citations

12.

Aitken, Samuel L, Mohammad Jahangir Alam, Seth T. Walk, et al.. (2015). In the Endemic Setting, Clostridium difficile Ribotype 027 Is Virulent But Not Hypervirulent. Infection Control and Hospital Epidemiology. 36(11). 1318–1323. 26 indexed citations

13.

Wei, Wenjing, et al.. (2015). Age-Stratified Treatment Response Rates in Hospitalized Patients with Clostridium difficile Infection Treated with Metronidazole. Antimicrobial Agents and Chemotherapy. 59(10). 6113–6116. 9 indexed citations

14.

Perez, Katherine K., Randall J. Olsen, William L. Musick, et al.. (2014). Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia. Journal of Infection. 69(3). 216–225. 233 indexed citations

15.

Long, S. Wesley, Randall J. Olsen, Shrenik Mehta, et al.. (2014). PBP2a Mutations Causing High-Level Ceftaroline Resistance in Clinical Methicillin-Resistant Staphylococcus aureus Isolates. Antimicrobial Agents and Chemotherapy. 58(11). 6668–6674. 113 indexed citations

16.

Jacobs, David M., Kristi Kuper, William L. Musick, et al.. (2013). Significant publications on infectious diseases pharmacotherapy in 2012. American Journal of Health-System Pharmacy. 70(21). 1930–1940. 12 indexed citations

17.

Tran, Truc T., Nicholas D. Beyda, Jessica Cottreau, et al.. (2012). Significant publications on infectious diseases pharmacotherapy in 2011. American Journal of Health-System Pharmacy. 69(19). 1671–1681. 11 indexed citations

18.

Palmer, Hannah R., Jessica Cottreau, Kevin W. Garey, et al.. (2010). Significant publications on infectious diseases pharmacotherapy in 2009. American Journal of Health-System Pharmacy. 67(15). e34–e42. 14 indexed citations

19.

Yeh, Rosa F., Kristi Kuper, Elizabeth A. Coyle, et al.. (2008). Significant publications on infectious diseases pharmacotherapy in 2007. American Journal of Health-System Pharmacy. 65(22). e72–e79. 9 indexed citations

20.

Flaker, Greg C., et al.. (1988). Prognosis in Patients with Left Ventricular Dysfunction and Ventricular Tachycardia Following Programmed Ventricular Stimulation. Journal of Cardiovascular Electrophysiology. 2(1). 23–29. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact